COP 1 for treatment of inflammatory bowel diseases

摘要

Provided is the use of Copolymer 1 for the preparation of a pharmaceutical composition for inhibiting weight loss, inducing weight regain or reducing macroscopic colonic 5 damage by at least 2.2 fold in a subject afflicted with mild to moderate Crohn's disease. The composition can be for oral administration or for injection. (62) Divided Out of 541376